Recording: Handling adverse events after intravesical instillations in NMIBC
The UROwebinar recording "Handling adverse events after intravesical instillations in NMIBC" is the 2nd episode of the UROwebinar series “Everything you always wanted to know about TURBT but were afraid to ask”. This recording will provide valuable insights and practical guidance for managing complications associated with intravesical treatments in non-muscle-invasive bladder cancer (NMIBC).
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | Not approved |
| Duration | Approx. 60 minutes |
The discussions will include effective strategies for addressing adverse reactions to Bacillus Calmette-Guérin (BCG) therapy, using real-world clinical cases to illustrate key points.
This recording will also cover the management of side effects and challenges posed by intravesical chemotherapy, again supported by case studies. In addition, participants will learn the importance of thorough patient education and current best practices to ensure that the patients are well-informed and prepared for their treatment journey.
This recording aims to enhance clinical practice and improve patient outcomes in NMIBC treatment.
Speakers:
Prof. P. Gontero (IT)
Prof. Dr. J.A. Witjes (NL)
Dr. L. Makaroff (GB)
Prof. T. Cai (IT)
Review and/or look forward to the other episodes of the series:
- Check out the 1st episode “How to handle peculiar situations in TURBT” via this link.
- The podcast episode on how to install intravesical therapy post-TURBT will air in September 2024.
- In November 2024, the 3rd episode will feature complicated cases in bladder cancer submitted by participants.
- The 4th episode on how to approach TURBT in muscle-invasive bladder cancer will take place in 2025.
Acknowledment
This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.